tiprankstipranks
Trending News
More News >
Annexin Pharmaceuticals AB (SE:ANNX)
:ANNX
Sweden Market

Annexin Pharmaceuticals AB (ANNX) Financial Statements

Compare
0 Followers

Annexin Pharmaceuticals AB Financial Overview

Annexin Pharmaceuticals AB's market cap is currently kr279.39M. The company's EPS TTM is kr-0.114; its P/E ratio is ―; Annexin Pharmaceuticals AB is scheduled to report earnings on ―, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenuekr 0.00kr 0.00kr 0.00kr 0.00kr 0.00
Gross Profitkr -193.00Kkr -193.00Kkr -192.00Kkr -193.00Kkr -193.00K
Operating Incomekr -44.18Mkr -40.72Mkr -51.23Mkr -43.74Mkr -28.33M
EBITDAkr -43.86Mkr -40.53Mkr -50.09Mkr -43.54Mkr -28.14M
Net Incomekr -44.05Mkr -40.73Mkr -53.05Mkr -44.74Mkr -28.39M
Balance Sheet
Cash & Short-Term Investmentskr 21.41Mkr 31.11Mkr 49.48Mkr 18.13Mkr 4.26M
Total Assetskr 26.76Mkr 36.68Mkr 52.79Mkr 25.16Mkr 16.04M
Total Debtkr 0.00kr 0.00kr 0.00kr 0.00kr 227.00K
Net Debtkr -21.41Mkr -31.11Mkr -49.48Mkr -18.13Mkr -4.04M
Total Liabilitieskr 7.95Mkr 6.53Mkr 6.06Mkr 4.52Mkr 4.55M
Stockholders' Equitykr 18.81Mkr 30.15Mkr 46.73Mkr 20.64Mkr 11.49M
Cash Flow
Free Cash Flowkr -43.40Mkr -41.16Mkr -45.02Mkr -39.20Mkr -25.73M
Operating Cash Flowkr -43.40Mkr -41.16Mkr -45.02Mkr -39.20Mkr -25.73M
Investing Cash Flowkr 96.00Kkr -260.00Kkr 0.00kr -96.00Kkr 0.00
Financing Cash Flowkr 33.61Mkr 23.06Mkr 76.37Mkr 53.16Mkr -229.00K
Currency in SEK

Annexin Pharmaceuticals AB Earnings and Revenue History

Annexin Pharmaceuticals AB Debt to Assets

Annexin Pharmaceuticals AB Cash Flow

Annexin Pharmaceuticals AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis